Promoter holding
64.27%
VL
Vivimed Labs Limited - Due diligence report
A 360° intelligence report on Vivimed Labs: trust score, financial health, credit view, compliance, directors, growth and distress signals -…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Vivimed Labs — 360° Intelligence Report
Generated from MCA filings & public records29/100
Trust Score
Caution Indicated
Vivimed Labs is assessed as Caution Indicated with a Trust Score of 29/100. Vivimed Labs is a public limited indian non-government company incorporated in 1988, operating in the FMCG sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.
Report generated on 10 Aug 2026 from the latest processed filings. Vivimed Labs Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreCaution Indicated
29/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
5/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
5/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
45/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
30/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
- Negative operating earnings - debt service depends on external support.
- Externally credit-rated (BB-).
Charges position: 16 open (932.51 cr) · 30 satisfied (791.99 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 13 | 48.0 cr |
| Axis Bank Limited | 8 | 48.0 cr |
| Ifci Limited | 2 | 48.0 cr |
| Export Import Bank Of India | 1 | 48.0 cr |
| State Bank Of Hyderabad | 5 | 48.0 cr |
| Allahabad Bank | 1 | 48.0 cr |
Compliance Score: 5/100 Caution Indicated
- Company status is "Under Cirp" - not Active.
- Annual filings current (balance sheet Mar 2025).
- Flagged by authority: BSE, SEBI, MSEI.
- Litigation present in 2 court forum(s).
- 1 auditor resignation(s) filed - latest: PCN & Associates on 2024-05-18.
- 7 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 45/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SANDEEP VARALWAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| APARNA BIDARKAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| JARUGULA SIVA PRASAD | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| HARI GOPAL JAMALAPURAM | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUBBARATHNAMMA PALEPU | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KOPPARTHI YUGANDHAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PHANINDERNATH PETASONTI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANTOSH VARALWAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUBHASH VARALWAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MANOHAR RAO VARALWAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Yugandhar Kopparthi | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Phanindernath Petasonti | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 12 directors on the board.
- PHANINDERNATH PETASONTI has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
13 allotment(s) · 0 transfer(s)
Promoters hold a minority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Finoso Pharma Private Limited | Subsidiary Company | 74.00% |
| Vivimed Holdings Limited | Subsidiary Company | 74.00% |
| Vivimed Labs Mauritius Limited | Subsidiary Company | 74.00% |
| Vivimed Labs Usa Inc. | Subsidiary Company | 74.00% |
| Yantra Green Power Private Limited | Associate Company | 74.00% |
Key managerial personnel: SANDEEP VARALWAR (Whole-time director) · PHANINDERNATH PETASONTI (CFO) · SANTOSH VARALWAR (Managing Director) · MANOHAR RAO VARALWAR (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 40 · Distress 30
Growth signals & trust indicators
Operating for 37+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Negative net worth.
Adverse company status: Under Cirp.
Compliance score is weak (5/100).
16 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence20/100
Caution indicated
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 3 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment23/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 16 open charge(s) of 932.51 cr already registered.
- Compliance gaps should be priced into terms.
Investor view25/100
Limited indicators at present
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
23 Jan 2025
Director appointed
Phanindernath Petasonti (Cfo)
10 Jan 2025
Director appointed
PHANINDERNATH PETASONTI (CFO)
11 Dec 2024
Director appointed
JARUGULA SIVA PRASAD (Director)
Director appointed
SUBBARATHNAMMA PALEPU (Director)
23 Feb 2024
Director ceased
RAMAKANTA TRIPATHY
22 Jun 2023
Charge satisfied
Others
14 Feb 2022
Director appointed
APARNA BIDARKAR (Director)
10 Jan 2022
Director ceased
UMANATH VARAHABHOTLA
30 Oct 2021
Charge satisfied
Others
15 Oct 2021
Director ceased
RAMESH KRISHNAMURTHY
17 Dec 2020
Charge created
Others - 232.00 cr
30 Nov 2020
Director ceased
BHAGVANTH RAO MAMIDPALLI
29 Jul 2020
Charge created
Others - 15.00 cr
10
Key Observations
Auto-generated from the data aboveRevenue declined 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
12 active director(s) / partner(s); review board churn before relying on management continuity.
7 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of BB- from Care.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a minority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 13 security allotment(s) - amounts available in the full report.
21 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Yogi Intermediates Private Limited | U24100GJ2010PTC063137 | Ahmedabad, Gujarat, India |
| Paamit Lab Private Limited | U24230TG2020PTC141169 | Hyderabad, Telangana, India |
| Vertellus | U24230GJ2009PTC058904 | Vapi, Gujarat, India |
| Shivalik Remedies Private Limited | U24232DL2005PTC133923 | New Delhi, Delhi, India |
| Shiva Biogenetic Pharmaceuticals Private Limited | U24032HP2005PTC010765 | Solan, Himachal Pradesh, India |
| Chemex Oil Pvt Ltd | U15141WB2006PTC107359 | Kolkata, West Bengal, India |
| Sacheerome | L74899DL1992PLC049258 | New Delhi, Delhi, India |
| Rajsha Organics Private Limited | U24231GJ1997PTC032758 | Vadodara, Gujarat, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Vivimed Labs before audits and certifications: compliance score 5/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Vivimed Labs: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Vivimed Labs - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Caution indicated. Trust score 29/100, distress signals and MSME payment-delay disclosures - know whether Vivimed Labs pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Vivimed Labs - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Vivimed Labs an active company?
Vivimed Labs has MCA status “Under Cirp” with a compliance score of 5/100 (Caution Indicated).
Is Vivimed Labs financially healthy?
Vivimed Labs has a Financial Health Score of 5/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Vivimed Labs?
Its overall Trust Score is 29/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Vivimed Labs?
Promoters hold a minority stake - exact percentages are in the full report. 12 active director(s) are on record.
Does Vivimed Labs have loans or charges against its assets?
16 open charge(s) are registered against its assets, and 30 earlier charge(s) stand satisfied.
Is Vivimed Labs up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 5/100 (Caution Indicated).
Is it risky to lend to Vivimed Labs?
Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
